_id
6911c6b5ccc777a4e85d6594
Ticker
HOOK
Name
Hookipa Pharma Inc
Exchange
NASDAQ
Address
350 Fifth Avenue, New York, NY, United States, 10118
Country
USA
Sector
Healthcare
Industry
Biotechnology
Currency
USD
Website
https://www.hookipapharma.com
Description
HOOKIPA Pharma Inc., a clinical stage biopharmaceutical company, develops immunetherapeutics targeting infectious diseases based on its proprietary arenavirus platform. The company's immuno-oncology pipeline includes HB-700, a novel next-generation multi-KRAS mutant-targeting investigational immunotherapy for the treatment of KRAS mutated cancers, including lung, colorectal, and pancreatic cancers; Eseba-vec, an investigational immunotherapeutic agent in clinical development for the treatment of Human Papillomavirus 16-positive (HPV16+) head and neck cancers with enrollment completed in a Phase 1/2 clinical trial; and HB-300, which targets self-antigens for the treatment of prostate cancer. It is also developing HB-400 for the treatment of Hepatitis B that is in Phase I of clinical trial; and HB-500 for the treatment of Human Immunodeficiency Virus (HIV) that is in Phase I of clinical trial. The company has a collaboration and license agreement with Gilead Sciences, Inc. to collaborate on preclinical research programs to evaluate potential vaccine products for the treatment, cure, diagnosis, or prevention of the hepatitis B virus (HBV) and the HIV. HOOKIPA Pharma Inc. was incorporated in 2011 and is headquartered in New York, New York.
Last Close
0.87
Volume
2561
Current Price
0.865
Change
-0.5747126436781614
Last Updated
2025-12-01T08:55:46.702Z
Image
data:image/webp;base64,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
Ipo Date
2019-04-18T00:00:00.000Z
Market Cap
10986302
Next Dividend Date
-
Dividend Frequency
-
Dividend Rate
-
Dividend Yield
0
Sentiment
-
Sentiment Sources
0
Rating
3.6667
Target Price
2
Strong Buy
1
Buy
0
Hold
2
Sell
0
Strong Sell
0
Current Quarter
2025-03-31
Revenue
2004000
Cost Of Revenue
699000
Gross Profit
2004000
Operating Expenses
19878000
Operating Income
-17874000
Interest Expense
0
Pretax Income
-15427000
Net Income
-15427000
Eps
-1.2300000414597798
Dividends Per Share
-
Shares Outstanding
9930789
Income Tax Expense
-106000
EBITDA
-15038000
Operating Margin
-891.9161676646708
Total Other Income Expense Net
2447000
Cash
40276000
Short Term Investments
-
Receivables
8307000
Inventories
-
Total Current Assets
60091000
Property Plant Equipment
686000
Total Assets
61256000
Payables
3670000
Short Term Debt
624000
Long Term Debt
-
Total Liabilities
27176000
Equity
34080000
Depreciation
389000
Change In Working Capital
15406000
Cash From Operations
52000
Capital Expenditures
20000
Cash From Investing
-20000
Cash From Financing
0
Net Change In Cash
594000
PE
-
PB
0.3183412188967136
ROE
-45.26701877934272
ROA
-25.184471725218753
FCF
32000
Fcf Percent
0.015968063872255488
Piotroski FScore
2
Health Score
30
Deep Value Investing Score
7.5
Defensive Investing Score
6.5
Dividend Investing Score
3
Economic Moat Investing Score
6.3
Garp Investing Score
5.5
Growth Investing Score
4.5
Momentum Investing Score
4
Net Net Investing Score
9.5
Quality Investing Score
4
Value Investing Score
5
Quarters > 0 > quarter
2025-03-31
Quarters > 0 > income Statement > revenue
2004000
Quarters > 0 > income Statement > cost Of Revenue
699000
Quarters > 0 > income Statement > gross Profit
2004000
Quarters > 0 > income Statement > operating Expenses
19878000
Quarters > 0 > income Statement > operating Income
-17874000
Quarters > 0 > income Statement > interest Expense
0
Quarters > 0 > income Statement > pretax Income
-15427000
Quarters > 0 > income Statement > net Income
-15427000
Quarters > 0 > income Statement > eps
-1.2300000414597798
Quarters > 0 > income Statement > dividends Per Share
-
Quarters > 0 > income Statement > shares Outstanding
12542276
Quarters > 0 > income Statement > income Tax Expense
-106000
Quarters > 0 > income Statement > EBITDA
-15038000
Quarters > 0 > income Statement > operating Margin
-891.9161676646708
Quarters > 0 > income Statement > total Other Income Expense Net
2447000
Quarters > 0 > balance Sheet > cash
40276000
Quarters > 0 > balance Sheet > short Term Investments
-
Quarters > 0 > balance Sheet > receivables
8307000
Quarters > 0 > balance Sheet > inventories
-
Quarters > 0 > balance Sheet > total Current Assets
60091000
Quarters > 0 > balance Sheet > property Plant Equipment
686000
Quarters > 0 > balance Sheet > total Assets
61256000
Quarters > 0 > balance Sheet > payables
3670000
Quarters > 0 > balance Sheet > short Term Debt
624000
Quarters > 0 > balance Sheet > long Term Debt
-
Quarters > 0 > balance Sheet > total Liabilities
27176000
Quarters > 0 > balance Sheet > equity
34080000
Quarters > 0 > cash Flow > net Income
-15427000
Quarters > 0 > cash Flow > depreciation
389000
Quarters > 0 > cash Flow > change In Working Capital
15406000
Quarters > 0 > cash Flow > cash From Operations
52000
Quarters > 0 > cash Flow > capital Expenditures
20000
Quarters > 0 > cash Flow > cash From Investing
-20000
Quarters > 0 > cash Flow > cash From Financing
0
Quarters > 0 > cash Flow > net Change In Cash
594000
Quarters > 0 > ratios > PE
-1.2300000414597798
Quarters > 0 > ratios > PB
0.3183412188967136
Quarters > 0 > ratios > ROE
-45.26701877934272
Quarters > 0 > ratios > ROA
-25.184471725218753
Quarters > 0 > ratios > FCF
32000
Quarters > 0 > ratios > Piotroski FScore
2
Quarters > 0 > ratios > fcf Percent
0.015968063872255488
Quarters > 0 > health Score
30
Quarters > 1 > quarter
2024-12-31
Quarters > 1 > income Statement > revenue
1354000
Quarters > 1 > income Statement > cost Of Revenue
-
Quarters > 1 > income Statement > gross Profit
1354000
Quarters > 1 > income Statement > operating Expenses
18518000
Quarters > 1 > income Statement > operating Income
-21459000
Quarters > 1 > income Statement > interest Expense
0
Quarters > 1 > income Statement > pretax Income
-25056000
Quarters > 1 > income Statement > net Income
-24950000
Quarters > 1 > income Statement > eps
-1.9898150181826824
Quarters > 1 > income Statement > dividends Per Share
-
Quarters > 1 > income Statement > shares Outstanding
12538854
Quarters > 1 > income Statement > income Tax Expense
-106000
Quarters > 1 > income Statement > EBITDA
-24357000
Quarters > 1 > income Statement > operating Margin
-1584.8596750369277
Quarters > 1 > income Statement > total Other Income Expense Net
-3597000
Quarters > 1 > balance Sheet > cash
39684000
Quarters > 1 > balance Sheet > short Term Investments
-
Quarters > 1 > balance Sheet > receivables
23670000
Quarters > 1 > balance Sheet > inventories
-
Quarters > 1 > balance Sheet > total Current Assets
80665000
Quarters > 1 > balance Sheet > property Plant Equipment
1064000
Quarters > 1 > balance Sheet > total Assets
82545000
Quarters > 1 > balance Sheet > payables
8687000
Quarters > 1 > balance Sheet > short Term Debt
1104000
Quarters > 1 > balance Sheet > long Term Debt
-
Quarters > 1 > balance Sheet > total Liabilities
31331000
Quarters > 1 > balance Sheet > equity
51214000
Quarters > 1 > cash Flow > net Income
-24950000
Quarters > 1 > cash Flow > depreciation
699000
Quarters > 1 > cash Flow > change In Working Capital
-1381000
Quarters > 1 > cash Flow > cash From Operations
-20938000
Quarters > 1 > cash Flow > capital Expenditures
2000
Quarters > 1 > cash Flow > cash From Investing
-2000
Quarters > 1 > cash Flow > cash From Financing
0
Quarters > 1 > cash Flow > net Change In Cash
-20071000
Quarters > 1 > ratios > PE
-1.9898150181826824
Quarters > 1 > ratios > PB
0.21178015210684578
Quarters > 1 > ratios > ROE
-48.7171476549381
Quarters > 1 > ratios > ROA
-30.22593736749652
Quarters > 1 > ratios > FCF
-20940000
Quarters > 1 > ratios > Piotroski FScore
1
Quarters > 1 > ratios > fcf Percent
-15.465288035450516
Quarters > 1 > health Score
30
Quarters > 2 > quarter
2024-09-30
Quarters > 2 > income Statement > revenue
4703000
Quarters > 2 > income Statement > cost Of Revenue
-
Quarters > 2 > income Statement > gross Profit
4703000
Quarters > 2 > income Statement > operating Expenses
23347000
Quarters > 2 > income Statement > operating Income
-18644000
Quarters > 2 > income Statement > interest Expense
0
Quarters > 2 > income Statement > pretax Income
-13841000
Quarters > 2 > income Statement > net Income
-13841000
Quarters > 2 > income Statement > eps
-1.1038559272222308
Quarters > 2 > income Statement > dividends Per Share
-
Quarters > 2 > income Statement > shares Outstanding
12538774
Quarters > 2 > income Statement > income Tax Expense
-13841000
Quarters > 2 > income Statement > EBITDA
-13141000
Quarters > 2 > income Statement > operating Margin
-396.42781203487135
Quarters > 2 > income Statement > total Other Income Expense Net
4803000
Quarters > 2 > balance Sheet > cash
59750000
Quarters > 2 > balance Sheet > short Term Investments
-
Quarters > 2 > balance Sheet > receivables
24990000
Quarters > 2 > balance Sheet > inventories
-
Quarters > 2 > balance Sheet > total Current Assets
93156000
Quarters > 2 > balance Sheet > property Plant Equipment
9722000
Quarters > 2 > balance Sheet > total Assets
109730000
Quarters > 2 > balance Sheet > payables
8955000
Quarters > 2 > balance Sheet > short Term Debt
2412000
Quarters > 2 > balance Sheet > long Term Debt
-
Quarters > 2 > balance Sheet > total Liabilities
37928000
Quarters > 2 > balance Sheet > equity
71802000
Quarters > 2 > cash Flow > net Income
-13841000
Quarters > 2 > cash Flow > depreciation
700000
Quarters > 2 > cash Flow > change In Working Capital
35384000
Quarters > 2 > cash Flow > cash From Operations
-17508000
Quarters > 2 > cash Flow > capital Expenditures
31000
Quarters > 2 > cash Flow > cash From Investing
-31000
Quarters > 2 > cash Flow > cash From Financing
0
Quarters > 2 > cash Flow > net Change In Cash
-17396000
Quarters > 2 > ratios > PE
-1.1038559272222308
Quarters > 2 > ratios > PB
0.15105483844461157
Quarters > 2 > ratios > ROE
-19.27662182111919
Quarters > 2 > ratios > ROA
-12.613688143625263
Quarters > 2 > ratios > FCF
-17539000
Quarters > 2 > ratios > Piotroski FScore
0
Quarters > 2 > ratios > fcf Percent
-3.7293217095470976
Quarters > 2 > health Score
29
Quarters > 3 > quarter
2024-06-30
Quarters > 3 > income Statement > revenue
1290000
Quarters > 3 > income Statement > cost Of Revenue
156000
Quarters > 3 > income Statement > gross Profit
1290000
Quarters > 3 > income Statement > operating Expenses
23748000
Quarters > 3 > income Statement > operating Income
-22458000
Quarters > 3 > income Statement > interest Expense
0
Quarters > 3 > income Statement > pretax Income
-19095000
Quarters > 3 > income Statement > net Income
-19095000
Quarters > 3 > income Statement > eps
-1.5228761599818292
Quarters > 3 > income Statement > dividends Per Share
-
Quarters > 3 > income Statement > shares Outstanding
12538774
Quarters > 3 > income Statement > income Tax Expense
-
Quarters > 3 > income Statement > EBITDA
-18381000
Quarters > 3 > income Statement > operating Margin
-1740.9302325581398
Quarters > 3 > income Statement > total Other Income Expense Net
3363000
Quarters > 3 > balance Sheet > cash
77150000
Quarters > 3 > balance Sheet > short Term Investments
-
Quarters > 3 > balance Sheet > receivables
22561000
Quarters > 3 > balance Sheet > inventories
-
Quarters > 3 > balance Sheet > total Current Assets
107351000
Quarters > 3 > balance Sheet > property Plant Equipment
12020000
Quarters > 3 > balance Sheet > total Assets
125046000
Quarters > 3 > balance Sheet > payables
11314000
Quarters > 3 > balance Sheet > short Term Debt
3014000
Quarters > 3 > balance Sheet > long Term Debt
-
Quarters > 3 > balance Sheet > total Liabilities
38982000
Quarters > 3 > balance Sheet > equity
86064000
Quarters > 3 > cash Flow > net Income
-19095000
Quarters > 3 > cash Flow > depreciation
714000
Quarters > 3 > cash Flow > change In Working Capital
3546000
Quarters > 3 > cash Flow > cash From Operations
-14376000
Quarters > 3 > cash Flow > capital Expenditures
45000
Quarters > 3 > cash Flow > cash From Investing
-45000
Quarters > 3 > cash Flow > cash From Financing
-1141000
Quarters > 3 > cash Flow > net Change In Cash
-15602000
Quarters > 3 > ratios > PE
-1.5228761599818292
Quarters > 3 > ratios > PB
0.12602295396449154
Quarters > 3 > ratios > ROE
-22.18697713329615
Quarters > 3 > ratios > ROA
-15.270380499976008
Quarters > 3 > ratios > FCF
-14421000
Quarters > 3 > ratios > Piotroski FScore
1
Quarters > 3 > ratios > fcf Percent
-11.179069767441861
Quarters > 3 > health Score
34
Annuals > 0 > quarter
2024-12-31
Annuals > 0 > income Statement > revenue
43946000
Annuals > 0 > income Statement > cost Of Revenue
2753000
Annuals > 0 > income Statement > gross Profit
41193000
Annuals > 0 > income Statement > operating Expenses
28268000
Annuals > 0 > income Statement > operating Income
-51455000
Annuals > 0 > income Statement > interest Expense
2000
Annuals > 0 > income Statement > pretax Income
-43609000
Annuals > 0 > income Statement > net Income
-43503000
Annuals > 0 > income Statement > eps
-3.4694779569358216
Annuals > 0 > income Statement > dividends Per Share
-
Annuals > 0 > income Statement > shares Outstanding
12538774
Annuals > 0 > income Statement > income Tax Expense
-106000
Annuals > 0 > income Statement > EBITDA
-40854000
Annuals > 0 > income Statement > operating Margin
-117.08687935193191
Annuals > 0 > income Statement > total Other Income Expense Net
7846000
Annuals > 0 > balance Sheet > cash
39684000
Annuals > 0 > balance Sheet > short Term Investments
-
Annuals > 0 > balance Sheet > receivables
23670000
Annuals > 0 > balance Sheet > inventories
-
Annuals > 0 > balance Sheet > total Current Assets
80665000
Annuals > 0 > balance Sheet > property Plant Equipment
1064000
Annuals > 0 > balance Sheet > total Assets
82545000
Annuals > 0 > balance Sheet > payables
8687000
Annuals > 0 > balance Sheet > short Term Debt
1104000
Annuals > 0 > balance Sheet > long Term Debt
-
Annuals > 0 > balance Sheet > total Liabilities
31331000
Annuals > 0 > balance Sheet > equity
51214000
Annuals > 0 > cash Flow > net Income
-43503000
Annuals > 0 > cash Flow > depreciation
2753000
Annuals > 0 > cash Flow > change In Working Capital
-42246000
Annuals > 0 > cash Flow > cash From Operations
-76978000
Annuals > 0 > cash Flow > capital Expenditures
194000
Annuals > 0 > cash Flow > cash From Investing
-194000
Annuals > 0 > cash Flow > cash From Financing
-1276000
Annuals > 0 > cash Flow > net Change In Cash
-77635000
Annuals > 0 > ratios > PE
-3.4694779569358216
Annuals > 0 > ratios > PB
0.21814440649041278
Annuals > 0 > ratios > ROE
-84.94357011754599
Annuals > 0 > ratios > ROA
-52.70216245684173
Annuals > 0 > ratios > FCF
-77172000
Annuals > 0 > ratios > Piotroski FScore
1
Annuals > 0 > ratios > fcf Percent
-1.7560642606835661
Annuals > 0 > health Score
30
Annuals > 1 > quarter
2023-12-31
Annuals > 1 > income Statement > revenue
20129000
Annuals > 1 > income Statement > cost Of Revenue
3552000
Annuals > 1 > income Statement > gross Profit
16577000
Annuals > 1 > income Statement > operating Expenses
117823000
Annuals > 1 > income Statement > operating Income
-97694000
Annuals > 1 > income Statement > interest Expense
317000
Annuals > 1 > income Statement > pretax Income
-81212000
Annuals > 1 > income Statement > net Income
-81580000
Annuals > 1 > income Statement > eps
-8.630378594122117
Annuals > 1 > income Statement > dividends Per Share
-
Annuals > 1 > income Statement > shares Outstanding
9452656
Annuals > 1 > income Statement > income Tax Expense
368000
Annuals > 1 > income Statement > EBITDA
-77343000
Annuals > 1 > income Statement > operating Margin
-485.33955983903815
Annuals > 1 > income Statement > total Other Income Expense Net
16482000
Annuals > 1 > balance Sheet > cash
117096000
Annuals > 1 > balance Sheet > short Term Investments
-
Annuals > 1 > balance Sheet > receivables
19271000
Annuals > 1 > balance Sheet > inventories
-
Annuals > 1 > balance Sheet > total Current Assets
147116000
Annuals > 1 > balance Sheet > property Plant Equipment
13215000
Annuals > 1 > balance Sheet > total Assets
161337000
Annuals > 1 > balance Sheet > payables
12498000
Annuals > 1 > balance Sheet > short Term Debt
2758000
Annuals > 1 > balance Sheet > long Term Debt
-
Annuals > 1 > balance Sheet > total Liabilities
71480000
Annuals > 1 > balance Sheet > equity
89857000
Annuals > 1 > cash Flow > net Income
-81580000
Annuals > 1 > cash Flow > depreciation
3552000
Annuals > 1 > cash Flow > change In Working Capital
5329000
Annuals > 1 > cash Flow > cash From Operations
-57524000
Annuals > 1 > cash Flow > capital Expenditures
4159000
Annuals > 1 > cash Flow > cash From Investing
-4159000
Annuals > 1 > cash Flow > cash From Financing
65670000
Annuals > 1 > cash Flow > net Change In Cash
4077000
Annuals > 1 > ratios > PE
-8.630378594122117
Annuals > 1 > ratios > PB
0.09373022130718808
Annuals > 1 > ratios > ROE
-90.78869759729348
Annuals > 1 > ratios > ROA
-50.56496649869528
Annuals > 1 > ratios > FCF
-61683000
Annuals > 1 > ratios > Piotroski FScore
0
Annuals > 1 > ratios > fcf Percent
-3.064384718565254
Annuals > 1 > health Score
29
Annuals > 2 > quarter
2022-12-31
Annuals > 2 > income Statement > revenue
14249000
Annuals > 2 > income Statement > cost Of Revenue
3602000
Annuals > 2 > income Statement > gross Profit
14249000
Annuals > 2 > income Statement > operating Expenses
87404000
Annuals > 2 > income Statement > operating Income
-73155000
Annuals > 2 > income Statement > interest Expense
687000
Annuals > 2 > income Statement > pretax Income
-64915000
Annuals > 2 > income Statement > net Income
-65145000
Annuals > 2 > income Statement > eps
-9.943834013911141
Annuals > 2 > income Statement > dividends Per Share
-
Annuals > 2 > income Statement > shares Outstanding
6551296
Annuals > 2 > income Statement > income Tax Expense
230000
Annuals > 2 > income Statement > EBITDA
-69553000
Annuals > 2 > income Statement > operating Margin
-513.404449435048
Annuals > 2 > income Statement > total Other Income Expense Net
8240000
Annuals > 2 > balance Sheet > cash
113444000
Annuals > 2 > balance Sheet > short Term Investments
-
Annuals > 2 > balance Sheet > receivables
22012000
Annuals > 2 > balance Sheet > inventories
-419000
Annuals > 2 > balance Sheet > total Current Assets
147196000
Annuals > 2 > balance Sheet > property Plant Equipment
21976000
Annuals > 2 > balance Sheet > total Assets
170454000
Annuals > 2 > balance Sheet > payables
5488000
Annuals > 2 > balance Sheet > short Term Debt
3282000
Annuals > 2 > balance Sheet > long Term Debt
911000
Annuals > 2 > balance Sheet > total Liabilities
67937000
Annuals > 2 > balance Sheet > equity
102517000
Annuals > 2 > cash Flow > net Income
-64915000
Annuals > 2 > cash Flow > depreciation
3602000
Annuals > 2 > cash Flow > change In Working Capital
36113000
Annuals > 2 > cash Flow > cash From Operations
-19997000
Annuals > 2 > cash Flow > capital Expenditures
5017000
Annuals > 2 > cash Flow > cash From Investing
-5017000
Annuals > 2 > cash Flow > cash From Financing
72271000
Annuals > 2 > cash Flow > net Change In Cash
46532000
Annuals > 2 > ratios > PE
-9.943834013911141
Annuals > 2 > ratios > PB
0.05693889536369578
Annuals > 2 > ratios > ROE
-63.5455582976482
Annuals > 2 > ratios > ROA
-38.218522299271356
Annuals > 2 > ratios > FCF
-25014000
Annuals > 2 > ratios > Piotroski FScore
0
Annuals > 2 > ratios > fcf Percent
-1.7554916134465577
Annuals > 2 > health Score
29
Annuals > 3 > quarter
2021-12-31
Annuals > 3 > income Statement > revenue
18448000
Annuals > 3 > income Statement > cost Of Revenue
4640000
Annuals > 3 > income Statement > gross Profit
18448000
Annuals > 3 > income Statement > operating Expenses
100122000
Annuals > 3 > income Statement > operating Income
-81674000
Annuals > 3 > income Statement > interest Expense
898000
Annuals > 3 > income Statement > pretax Income
-75665000
Annuals > 3 > income Statement > net Income
-75666000
Annuals > 3 > income Statement > eps
-23.045302082410117
Annuals > 3 > income Statement > dividends Per Share
-
Annuals > 3 > income Statement > shares Outstanding
3283359
Annuals > 3 > income Statement > income Tax Expense
1000
Annuals > 3 > income Statement > EBITDA
-77034000
Annuals > 3 > income Statement > operating Margin
-442.72549869904594
Annuals > 3 > income Statement > total Other Income Expense Net
6009000
Annuals > 3 > balance Sheet > cash
65921000
Annuals > 3 > balance Sheet > short Term Investments
-
Annuals > 3 > balance Sheet > receivables
21166000
Annuals > 3 > balance Sheet > inventories
-14271000
Annuals > 3 > balance Sheet > total Current Assets
102135000
Annuals > 3 > balance Sheet > property Plant Equipment
22115000
Annuals > 3 > balance Sheet > total Assets
126045000
Annuals > 3 > balance Sheet > payables
8762000
Annuals > 3 > balance Sheet > short Term Debt
4495000
Annuals > 3 > balance Sheet > long Term Debt
2219000
Annuals > 3 > balance Sheet > total Liabilities
36453000
Annuals > 3 > balance Sheet > equity
89592000
Annuals > 3 > cash Flow > net Income
-75665000
Annuals > 3 > cash Flow > depreciation
4640000
Annuals > 3 > cash Flow > change In Working Capital
-3861000
Annuals > 3 > cash Flow > cash From Operations
-66016000
Annuals > 3 > cash Flow > capital Expenditures
12581000
Annuals > 3 > cash Flow > cash From Investing
-12581000
Annuals > 3 > cash Flow > cash From Financing
-235000
Annuals > 3 > cash Flow > net Change In Cash
-76265000
Annuals > 3 > ratios > PE
-23.045302082410117
Annuals > 3 > ratios > PB
0.03265328231315296
Annuals > 3 > ratios > ROE
-84.45620144655773
Annuals > 3 > ratios > ROA
-60.030941330477205
Annuals > 3 > ratios > FCF
-78597000
Annuals > 3 > ratios > Piotroski FScore
0
Annuals > 3 > ratios > fcf Percent
-4.2604618386816995
Annuals > 3 > health Score
33
Valuation > metrics > PE
-1.2300000414597798
Valuation > metrics > PB
0.3183412188967136
Valuation > final Score
70
Valuation > verdict
68.2% Undervalued
Profitability > metrics > ROE
-45.26701877934272
Profitability > metrics > ROA
-25.672729693298496
Profitability > metrics > Net Margin
-7.69810379241517
Profitability > final Score
0
Profitability > verdict
Weak
Risk > metrics > Debt Equity
0.7974178403755868
Risk > metrics > Interest Coverage
-45.94858611825193
Risk > final Score
-136
Risk > verdict
High
Liquidity > metrics > Current Ratio
13.994177922682812
Liquidity > metrics > Quick Ratio
13.994177922682812
Liquidity > final Score
100
Liquidity > verdict
Great
Prev Valuations > 0
70
Prev Valuations > 1
70
Prev Valuations > 2
70
Prev Profitabilities > 0
0
Prev Profitabilities > 1
0
Prev Profitabilities > 2
0
Prev Risks > 0
-75
Prev Risks > 1
-59
Prev Risks > 2
-66
Prev Liquidities > 0
100
Prev Liquidities > 1
100
Prev Liquidities > 2
100
Updated At
2025-12-16T22:47:36.408Z
Earnings History > 0 > period
2025-03-31
Earnings History > 0 > report Date
2025-05-07
Earnings History > 0 > date
2025-03-31
Earnings History > 0 > before After Market
BeforeMarket
Earnings History > 0 > currency
USD
Earnings History > 0 > eps Actual
-1.2192
Earnings History > 0 > eps Estimate
-1.04
Earnings History > 0 > eps Difference
-0.1792
Earnings History > 0 > surprise Percent
-17.2308
Earnings History > 1 > period
2024-12-31
Earnings History > 1 > report Date
2025-03-20
Earnings History > 1 > date
2024-12-31
Earnings History > 1 > before After Market
BeforeMarket
Earnings History > 1 > currency
USD
Earnings History > 1 > eps Actual
-0.74
Earnings History > 1 > eps Estimate
-0.69
Earnings History > 1 > eps Difference
-0.05
Earnings History > 1 > surprise Percent
-7.2464
Earnings History > 2 > period
2024-09-30
Earnings History > 2 > report Date
2024-11-07
Earnings History > 2 > date
2024-09-30
Earnings History > 2 > before After Market
BeforeMarket
Earnings History > 2 > currency
USD
Earnings History > 2 > eps Actual
-1.1
Earnings History > 2 > eps Estimate
-1.28
Earnings History > 2 > eps Difference
0.18
Earnings History > 2 > surprise Percent
14.0625
Earnings History > 3 > period
2024-06-30
Earnings History > 3 > report Date
2024-08-08
Earnings History > 3 > date
2024-06-30
Earnings History > 3 > before After Market
AfterMarket
Earnings History > 3 > currency
USD
Earnings History > 3 > eps Actual
-1.52
Earnings History > 3 > eps Estimate
-1.25
Earnings History > 3 > eps Difference
-0.27
Earnings History > 3 > surprise Percent
-21.6
Earnings History > 4 > period
2024-03-31
Earnings History > 4 > report Date
2024-05-09
Earnings History > 4 > date
2024-03-31
Earnings History > 4 > before After Market
BeforeMarket
Earnings History > 4 > currency
USD
Earnings History > 4 > eps Actual
0.11
Earnings History > 4 > eps Estimate
-0.1
Earnings History > 4 > eps Difference
0.21
Earnings History > 4 > surprise Percent
210
Earnings History > 5 > period
2023-12-31
Earnings History > 5 > report Date
2024-03-22
Earnings History > 5 > date
2023-12-31
Earnings History > 5 > before After Market
BeforeMarket
Earnings History > 5 > currency
USD
Earnings History > 5 > eps Actual
-0.22
Earnings History > 5 > eps Estimate
-0.19
Earnings History > 5 > eps Difference
-0.03
Earnings History > 5 > surprise Percent
-15.7895
Earnings History > 6 > period
2023-09-30
Earnings History > 6 > report Date
2023-11-09
Earnings History > 6 > date
2023-09-30
Earnings History > 6 > before After Market
BeforeMarket
Earnings History > 6 > currency
USD
Earnings History > 6 > eps Actual
-0.17
Earnings History > 6 > eps Estimate
-0.21
Earnings History > 6 > eps Difference
0.04
Earnings History > 6 > surprise Percent
19.0476
Earnings History > 7 > period
2023-06-30
Earnings History > 7 > report Date
2023-08-10
Earnings History > 7 > date
2023-06-30
Earnings History > 7 > before After Market
BeforeMarket
Earnings History > 7 > currency
USD
Earnings History > 7 > eps Actual
-0.22
Earnings History > 7 > eps Estimate
-0.21
Earnings History > 7 > eps Difference
-0.01
Earnings History > 7 > surprise Percent
-4.7619
Earnings History > 8 > period
2023-03-31
Earnings History > 8 > report Date
2023-05-11
Earnings History > 8 > date
2023-03-31
Earnings History > 8 > before After Market
BeforeMarket
Earnings History > 8 > currency
USD
Earnings History > 8 > eps Actual
-0.27
Earnings History > 8 > eps Estimate
-0.23
Earnings History > 8 > eps Difference
-0.04
Earnings History > 8 > surprise Percent
-17.3913
Earnings History > 9 > period
2022-12-31
Earnings History > 9 > report Date
2023-03-15
Earnings History > 9 > date
2022-12-31
Earnings History > 9 > before After Market
BeforeMarket
Earnings History > 9 > currency
USD
Earnings History > 9 > eps Actual
-0.17
Earnings History > 9 > eps Estimate
-0.21
Earnings History > 9 > eps Difference
0.04
Earnings History > 9 > surprise Percent
19.0476
Earnings History > 10 > period
2022-09-30
Earnings History > 10 > report Date
2022-11-14
Earnings History > 10 > date
2022-09-30
Earnings History > 10 > before After Market
BeforeMarket
Earnings History > 10 > currency
USD
Earnings History > 10 > eps Actual
-0.25
Earnings History > 10 > eps Estimate
-0.28
Earnings History > 10 > eps Difference
0.03
Earnings History > 10 > surprise Percent
10.7143
Earnings History > 11 > period
2022-06-30
Earnings History > 11 > report Date
2022-08-11
Earnings History > 11 > date
2022-06-30
Earnings History > 11 > before After Market
BeforeMarket
Earnings History > 11 > currency
USD
Earnings History > 11 > eps Actual
-0.23
Earnings History > 11 > eps Estimate
-0.36
Earnings History > 11 > eps Difference
0.13
Earnings History > 11 > surprise Percent
36.1111
Earnings History > 12 > period
2022-03-31
Earnings History > 12 > report Date
2022-05-16
Earnings History > 12 > date
2022-03-31
Earnings History > 12 > before After Market
BeforeMarket
Earnings History > 12 > currency
USD
Earnings History > 12 > eps Actual
-0.4
Earnings History > 12 > eps Estimate
-0.24
Earnings History > 12 > eps Difference
-0.16
Earnings History > 12 > surprise Percent
-66.6667
Earnings History > 13 > period
2021-12-31
Earnings History > 13 > report Date
2022-03-24
Earnings History > 13 > date
2021-12-31
Earnings History > 13 > before After Market
BeforeMarket
Earnings History > 13 > currency
USD
Earnings History > 13 > eps Actual
-0.65
Earnings History > 13 > eps Estimate
-0.58
Earnings History > 13 > eps Difference
-0.07
Earnings History > 13 > surprise Percent
-12.069
Earnings History > 14 > period
2021-09-30
Earnings History > 14 > report Date
2021-11-10
Earnings History > 14 > date
2021-09-30
Earnings History > 14 > before After Market
BeforeMarket
Earnings History > 14 > currency
USD
Earnings History > 14 > eps Actual
-0.61
Earnings History > 14 > eps Estimate
-0.52
Earnings History > 14 > eps Difference
-0.09
Earnings History > 14 > surprise Percent
-17.3077
Earnings History > 15 > period
2021-06-30
Earnings History > 15 > report Date
2021-08-12
Earnings History > 15 > date
2021-06-30
Earnings History > 15 > before After Market
BeforeMarket
Earnings History > 15 > currency
USD
Earnings History > 15 > eps Actual
-0.52
Earnings History > 15 > eps Estimate
-0.53
Earnings History > 15 > eps Difference
0.01
Earnings History > 15 > surprise Percent
1.8868
Earnings History > 16 > period
2021-03-31
Earnings History > 16 > report Date
2021-05-12
Earnings History > 16 > date
2021-03-31
Earnings History > 16 > before After Market
BeforeMarket
Earnings History > 16 > currency
USD
Earnings History > 16 > eps Actual
-0.53
Earnings History > 16 > eps Estimate
-0.53
Earnings History > 16 > eps Difference
0
Earnings History > 16 > surprise Percent
0
Earnings History > 17 > period
2020-12-31
Earnings History > 17 > report Date
2021-03-18
Earnings History > 17 > date
2020-12-31
Earnings History > 17 > before After Market
BeforeMarket
Earnings History > 17 > currency
USD
Earnings History > 17 > eps Actual
-0.46
Earnings History > 17 > eps Estimate
-0.58
Earnings History > 17 > eps Difference
0.12
Earnings History > 17 > surprise Percent
20.6897
Earnings History > 18 > period
2020-09-30
Earnings History > 18 > report Date
2020-11-12
Earnings History > 18 > date
2020-09-30
Earnings History > 18 > before After Market
BeforeMarket
Earnings History > 18 > currency
USD
Earnings History > 18 > eps Actual
-0.53
Earnings History > 18 > eps Estimate
-0.43
Earnings History > 18 > eps Difference
-0.1
Earnings History > 18 > surprise Percent
-23.2558
Earnings History > 19 > period
2020-06-30
Earnings History > 19 > report Date
2020-08-13
Earnings History > 19 > date
2020-06-30
Earnings History > 19 > before After Market
BeforeMarket
Earnings History > 19 > currency
USD
Earnings History > 19 > eps Actual
-0.28
Earnings History > 19 > eps Estimate
-0.47
Earnings History > 19 > eps Difference
0.19
Earnings History > 19 > surprise Percent
40.4255
Earnings History > 20 > period
2020-03-31
Earnings History > 20 > report Date
2020-05-14
Earnings History > 20 > date
2020-03-31
Earnings History > 20 > before After Market
BeforeMarket
Earnings History > 20 > currency
USD
Earnings History > 20 > eps Actual
-0.43
Earnings History > 20 > eps Estimate
-0.42
Earnings History > 20 > eps Difference
-0.01
Earnings History > 20 > surprise Percent
-2.381
Earnings History > 21 > period
2019-12-31
Earnings History > 21 > report Date
2020-03-19
Earnings History > 21 > date
2019-12-31
Earnings History > 21 > before After Market
BeforeMarket
Earnings History > 21 > currency
USD
Earnings History > 21 > eps Actual
-0.4
Earnings History > 21 > eps Estimate
-0.47
Earnings History > 21 > eps Difference
0.07
Earnings History > 21 > surprise Percent
14.8936
Earnings History > 22 > period
2019-09-30
Earnings History > 22 > report Date
2019-11-12
Earnings History > 22 > date
2019-09-30
Earnings History > 22 > before After Market
AfterMarket
Earnings History > 22 > currency
USD
Earnings History > 22 > eps Actual
-0.45
Earnings History > 22 > eps Estimate
-0.65
Earnings History > 22 > eps Difference
0.2
Earnings History > 22 > surprise Percent
30.7692
Earnings History > 23 > period
2019-06-30
Earnings History > 23 > report Date
2019-08-12
Earnings History > 23 > date
2019-06-30
Earnings History > 23 > before After Market
AfterMarket
Earnings History > 23 > currency
USD
Earnings History > 23 > eps Actual
-0.63
Earnings History > 23 > eps Estimate
-0.51
Earnings History > 23 > eps Difference
-0.12
Earnings History > 23 > surprise Percent
-23.5294
Earnings History > 24 > period
2019-03-31
Earnings History > 24 > report Date
2019-05-20
Earnings History > 24 > date
2019-03-31
Earnings History > 24 > before After Market
AfterMarket
Earnings History > 24 > currency
USD
Earnings History > 24 > eps Actual
-9.27
Earnings History > 24 > eps Estimate
-1.49
Earnings History > 24 > eps Difference
-7.78
Earnings History > 24 > surprise Percent
-522.1477
Earnings History > 25 > period
2018-12-31
Earnings History > 25 > report Date
2019-02-27
Earnings History > 25 > date
2018-12-31
Earnings History > 25 > before After Market
-
Earnings History > 25 > currency
USD
Earnings History > 25 > eps Actual
-0.29
Earnings History > 25 > eps Estimate
0
Earnings History > 25 > eps Difference
-0.29
Earnings History > 25 > surprise Percent
-
HOOKIPA Pharma Inc., a clinical stage biopharmaceutical company, develops immunetherapeutics targeting infectious diseases based on its proprietary arenavirus platform. The company's immuno-oncology pipeline includes HB-700, a novel next-generation multi-KRAS mutant-targeting investigational immunotherapy for the treatment of KRAS mutated cancers, including lung, colorectal, and pancreatic cancers; Eseba-vec, an investigational immunotherapeutic agent in clinical development for the treatment of Human Papillomavirus 16-positive (HPV16+) head and neck cancers with enrollment completed in a Phase 1/2 clinical trial; and HB-300, which targets self-antigens for the treatment of prostate cancer. It is also developing HB-400 for the treatment of Hepatitis B that is in Phase I of clinical trial; and HB-500 for the treatment of Human Immunodeficiency Virus (HIV) that is in Phase I of clinical trial. The company has a collaboration and license agreement with Gilead Sciences, Inc. to collaborate on preclinical research programs to evaluate potential vaccine products for the treatment, cure, diagnosis, or prevention of the hepatitis B virus (HBV) and the HIV. HOOKIPA Pharma Inc. was incorporated in 2011 and is headquartered in New York, New York.
Stock Price
$ 0.00
0% decrease compared to yesterday.
Dividend
Frequency:
Rate:
N/ANext Payout:
N/AHOOK Stock Analysis and Forecast - IPO Market Watch & Small Budget Big Profits - earlytimes.in
12/16/2025
HOOK Stock Analysis and Forecast - IPO Market Watch & Small Budget Big Profits earlytimes.in
Read more →Showing 2 of 10
(Last Updated 2025-03-31)
Rating:
BUY
Target Price:
$2
Analyst Picks
Strong Buy
1
Buy
0
Hold
2
Sell
0
Strong Sell
0
(Last Updated 2025-03-31)
Health Score
Price to Book Ratio (P/B)
-
Very Low
Low ≤ 1
High ≥ 3
Return on Equity (ROE)
-
Very Low
Low ≤ 5%
High ≥ 25%
Return on Assets (ROA)
-
Very Low
Low ≤ 2%
High ≥ 10%
Free Cash Flow - Revenue % (FCF)
-
Very Low
Low ≤ 5%
High ≥ 15%
Debt to Equity
-
Low
Low ≥ 1
High ≤ 0.3
* Institutions hold a combined 24.41% of the total shares of Hookipa Pharma Inc
1.
Baker Bros Advisors LP(6.6632%)
since
2025/06/30
2.
Siren, L.L.C.(4.6451%)
since
2025/06/30
3.
FMR Inc(2.7383%)
since
2025/06/30
4.
Vanguard Group Inc(2.466%)
since
2025/06/30
5.
Vanguard Total Stock Mkt Idx Inv(1.8322%)
since
2025/07/31
6.
Fidelity VIP Growth Initial(0.8316%)
since
2025/07/31
7.
Geode Capital Management, LLC(0.6012%)
since
2025/06/30
8.
Fidelity Advisor Equity Growth I(0.5481%)
since
2025/07/31
9.
Ikarian Capital, LLC(0.4344%)
since
2025/06/30
10.
Vanguard Institutional Extnd Mkt Idx Tr(0.3933%)
since
2025/07/31
11.
Renaissance Technologies Corp(0.3736%)
since
2025/06/30
12.
Fidelity Growth Discovery(0.3695%)
since
2025/07/31
13.
Fidelity Extended Market Index(0.3167%)
since
2025/07/31
14.
Susquehanna International Group, LLP(0.3055%)
since
2025/06/30
15.
Royal Bank of Canada(0.2365%)
since
2025/06/30
16.
Dimensional Fund Advisors, Inc.(0.1963%)
since
2025/06/30
17.
Morgan Stanley - Brokerage Accounts(0.1578%)
since
2025/06/30
18.
State Street Corp(0.1391%)
since
2025/06/30
19.
Northern Trust Corp(0.1284%)
since
2025/06/30
20.
Fidelity Advisor Series Equity Gr(0.1101%)
since
2025/07/31
21.
BlackRock Inc(0.1004%)
since
2025/06/30
22.
BOOTHBAY FUND MANAGEMENT, LLC(0.0958%)
since
2025/06/30
23.
Fidelity Total Market Index(0.0923%)
since
2025/07/31
24.
Fidelity Series Total Market Index(0.0767%)
since
2025/07/31
25.
Pacific Select Large-Cap Growth I(0.0726%)
since
2025/08/31
26.
NT Ext Equity Mkt Idx Fd - NL(0.0705%)
since
2025/06/30
27.
NT Ext Equity Mkt Idx Fd - L(0.0552%)
since
2025/06/30
28.
Northern Trust Extended Eq Market Idx(0.0552%)
since
2025/06/30
29.
NT Ext Equity Mkt Idx Fd - DC - NL - T2(0.0548%)
since
2025/06/30
30.
Spartan Total Market Index Pool G(0.0468%)
since
2025/07/31
31.
Extended Equity Market Fund K(0.0437%)
since
2025/06/30
32.
Spartan Extended Market Index Pool F(0.037%)
since
2025/07/31
33.
Fidelity Nasdaq Composite Index(0.0313%)
since
2025/07/31
34.
Tower Research Capital LLC(0.0285%)
since
2025/06/30
35.
Vanguard U.S. Eq Idx ÂŁ Acc(0.0212%)
since
2025/07/31
36.
Guardian Large Cap Fundamental Gr VIP(0.0186%)
since
2025/06/30
37.
JPMorgan Chase & Co(0.0067%)
since
2025/06/30
38.
Advisor Group Holdings, Inc.(0.0041%)
since
2025/06/30
39.
Bank of America Corp(0.0039%)
since
2025/06/30
40.
SIMPLEX TRADING, LLC(0.0028%)
since
2025/06/30
* Investors data is estimated based on stocks listed on Finnton that are currently held by Institution/Fund.
Date
—
EPS Estimate
—
Date
2025-03-31
EPS Actual
-1.2192
EPS Estimate
-1.04
EPS Difference
-0.1792
Surprise Percent
-17.2308%
(Last Updated 2025-03-31)
(Last Updated 2025-03-31)
Revenue
$ 0
Cost Of Revenue
$ 0
Gross Profit
$ 0
Operating Expenses
$ 0
Operating Income
$ 0
Interest Expense
$ 0
Pretax Income
$ 0
Net Income
$ 0
Income Tax Expense
$ 0
EBITDA
$ 0
Total Other Income Expense Net
$ 0
Earnings Per Share
0
Dividends Per Share
0
Shares Outstanding
0
Operating Margin
0%
(Last Updated 2025-03-31)
Cash
$ 0
Short Term Investments
$ 0
Receivables
$ 0
Inventories
$ 0
Total Current Assets
$ 0
Property Plant Equipment
$ 0
Total Assets
$ 0
Payables
$ 0
Short Term Debt
$ 0
Long Term Debt
$ 0
Total Liabilities
$ 0
Equity
$ 0
(Last Updated 2025-03-31)
Net Income
$ 0
Depreciation
$ 0
Change In Working Capital
$ 0
Cash From Operations
$ 0
Capital Expenditures
$ 0
Cash From Investing
$ 0
Cash From Financing
$ 0
Net Change In Cash
$ 0
Disclaimer: Finnton is a stock screener tool provided for informational and educational purposes only. The data, analysis, and insights offered on this website do not constitute financial, investment, tax, or legal advice. Users are solely responsible for their own investment decisions, and Finnton makes no guarantees regarding the accuracy, completeness, or reliability of the information provided. Past performance is not indicative of future results. Always conduct your own research and consult with a licensed financial advisor before making any investment decisions.